| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046520457 |
| P356 | DOI | 10.1038/EYE.1997.183 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/eye.1997.183 |
| P698 | PubMed publication ID | 9474324 |
| P2093 | author name string | Davis G | |
| Goodman S | |||
| Harrad RA | |||
| Potts MJ | |||
| Ghabrial R | |||
| Tomlinson M | |||
| Claridge KG | |||
| P2860 | cites work | Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 |
| Systemic management of dysthyroid ophthalmopathy | Q39545147 | ||
| Immunosuppressive therapy for the eye changes of Graves' disease | Q47769921 | ||
| Modification of the Classification of the Eye Changes of Graves' Disease | Q67021590 | ||
| Supervoltage orbital radiotherapy for Graves' ophthalmopathy | Q67249584 | ||
| Treatment of acute Graves orbitopathy | Q68049975 | ||
| Prognostic factors in the radiotherapy of Graves' ophthalmopathy | Q68353384 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| Radiation therapy for Graves' ophthalmopathy: a retrospective analysis | Q69447386 | ||
| The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy | Q69498905 | ||
| Current trends in orbital decompression | Q69801652 | ||
| Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results | Q69805593 | ||
| Orbital Cobalt Irradiation Combined with Systemic Corticosteroids for Graves' Ophthalmopathy: Comparison with Systemic Corticosteroids Alone* | Q70251349 | ||
| Pathogenesis of Graves' ophthalmopathy | Q70513409 | ||
| Radiation therapy for Graves' disease | Q71245706 | ||
| An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy | Q71545898 | ||
| Uniocular fields of fixation in thyroid eye disease | Q71736454 | ||
| Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy | Q71860538 | ||
| Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement | Q71864205 | ||
| Thyroid eye disease | Q71928257 | ||
| Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy | Q72235149 | ||
| The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease | Q72459779 | ||
| Use of eye muscle antibody measurements to monitor response to plasmapheresis in patients with thyroid-associated ophthalmopathy | Q72663755 | ||
| Radiation therapy for thyroid eye diseases | Q93588690 | ||
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 717-722 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease | |
| P478 | volume | 11 ( Pt 5) |
| Q74216803 | An ounce of prevention is worth a pound of cure? |
| Q73488546 | An unusual presentation of Graves' disease |
| Q49360082 | Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial. |
| Q30481543 | Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial |
| Q73415094 | Results of a neurosurgical two-wall orbital decompression in the treatment of severe thyroid associated ophthalmopathy |
| Q74192624 | Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease |
| Q42919451 | The Role of Intravenous Methylprednisolone Immunosuppression in the Management of Active Thyroid Eye Disease |
| Q73239445 | Thyroid Eye Disease |
| Q37060528 | Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management. |
Search more.